US Specialty Formulations Biotech Bulletin
Lehigh Valley biopharmaceutical company announces $15M expansion
US Specialty Formulations Announces $15 Million Expansion to Modernize Biopharma Operations
Heroes Of The COVID Crisis: How Kyle Y Flanigan Stepped Up To Make A Difference During The Covid-19 Pandemic
US specialty formulations completes phase I of clinical trials for the Qyndr Vaccine
USSF collaboration (VaxForm) amongst the select few on list of nextgen SARS-CoV-2 mucosal vaccine candidates in use or in clinical development.
Fact sheet
The independent biotech facility is on a mission to bring a mucosal COVID vaccine to market and mitigate the spread of the virus worldwide
In a race to develop an oral covid-19 vaccine, this small, black-owned bio-tech company has a solution
US specialty formulations wins ben franklin technology partners of northeastern pennsylvania's R. CHADWICK PAUL, JR. INCUBATOR Graduate award
A kinder vaccine coming for cold & flu season
Investors discover a kinder vaccine at J.P. Morgan biotech forum
Research demonstrates benefits of oral covid-19 vaccine
Discover a kinder oral vaccine at the world vaccine congress
Future COVID Vaccines Must Be Better; Science Races to Respond
Inspirational Black Men and Women in Medicine: Kyle Flanigan of US Specialty Formulations On 5 Things You Need To Create A Successful Career In Medicine
Kyle Flannigan and the Kinder COVID Vaccine
COVID-19 Vaccines You Can Drink, Snort or Inhale Could Be the Future
Living in the Lehigh Valley
Startup USSF bringing oral COVID vaccine to market
Meet Kyle Flanigan, Ph.D
Dr Kyle Flanigan On The Future Of Travel In The Post COVID World
Q&A With Dr. Kyle Flanigan, Ph.D., Co-Founder And CEO Of USSF
Allentown Pharma Firm Hopes To Soon Have Oral Vaccine To Market
Ben Franklin Technology Partners iXchange honors innovation
Living In The Lehigh Valley: Oral COVID-19 Vaccines Promises To Expand The Number Of People Vaccinated .
Allentown Biopharmaceutical Firm Calls Oral COVID-19 Vaccine A Game Changer
The Supply-Chain Empire
Meet The Next Generation Of Black Leaders And Entrepreneurs
Kyle Flanigan, CEO And Co-Founder Of U.S. Specialty Formulations, Talks About The Company Thursday, Feb. 10, 2022, At Its Facility In Allentown. The Biotech Company Is Working To Develop An Oral COVID Vaccine.
First-In-Human Study Of Orally Administered CoV2-OGEN1 In Healthy Subjects
Husband Of Vice President Kamala Harris Meets With Manufacturers And Business Owners At AEDC’s Bridgeworks Center
USSF to Manufacture Oral Covid-19 Vaccine for 2021 Distribution
Pharmaceutical company expanding Allentown operations
Oral COVID-19 Vaccine Developed In PA May Be Ready In Early 2021
Allentown pharmaceutical firm expanding to help create COVID-19 vaccines
USSF and Vaxform Developing Oral COVID-19 Vaccine
A COVID-19 vaccine that you drink? That’s what a company expanding in Allentown is working on
Pa. company hopes FDA will authorize oral COVID-19 vaccine
Governor Wolf Announces Life Sciences Partnership to Create Jobs, Develop COVID-19 Vaccine
Eastern Pa. companies partner in development of ingestible vaccine
Pennsylvania DCED Press Conference
The Faces of Ben Franklin: Re-Thinking What is Possible in Northeast Pa.
Lehigh Valley firms hope to bring COVID-19 vaccine to market by next year
USSF’s COVID-19 Oral and Injectable Vaccines Yield Positive Pre-Clinical Results
Joint Development of Novel Delivery COVID-19 Vaccines Yields Positive Pre-Clinical Results for 2021 Release
Allentown start-up pharmaceutical manufacturer USSF fighting against COVID-19
Specialty formulations pharmaceutical manufacturer chooses Allentown for expansion
Pharmaceutical maker embarks on Allentown expansion
Bethlehem pharmaceutical firm expanding, hiring
Governor Wolf Continues “Jobs That Pay” Tour at TechVentures
Chemists jump on pharma niche
US Specialty Formulations Awarded Investment from Ben Franklin Technology Partners
